About Enhancer
| Enhancer ID: |
E_01_0313 |
| Species: |
human |
| Position :
|
chr19:15232704-15234704
  |
| Biosample name: |
|
| Experiment class :
|
High+Lowthroughput |
| Enhancer type: |
Enhancer |
| Disease: |
Liver cancer |
| Pubmed ID: |
30659195
|
| Enhancer experiment: |
PCR?Western blot?ChIP-seq |
| Enhancer experiment description: |
Conversely, deletion of this enhancer via CRISPR/Cas9 reduces C/EBP? expression and its genome-wide co-occupancy with BRD4 at H3K27ac-marked enhancers and super-enhancers |
About Target gene
| Target gene : |
-- |
| Strong evidence: |
qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: |
RNA-Seq |
| Target gene experiment description: |
Conversely, deletion of this enhancer via CRISPR/Cas9 reduces C/EBP? expression and its genome-wide co-occupancy with BRD4 at H3K27ac-marked enhancers and super-enhancers |
About TF
| TF name : |
BRD4(CAP,HUNK1,HUNKI,MCAP) |
| TF experiment: |
PCR?Western blot?ChIP-seq |
| TF experiment description: |
Conversely, deletion of this enhancer via CRISPR/Cas9 reduces C/EBP? expression and its genome-wide co-occupancy with BRD4 at H3K27ac-marked enhancers and super-enhancers |
About Function
| Enhancer function : |
Conversely, deletion of this enhancer via CRISPR/Cas9 reduces C/EBP? expression and its genome-wide co-occupancy with BRD4 at H3K27ac-marked enhancers and super-enhancers |
| Enhancer function experiment: |
Immunohistochemical staining |
Enhancer function
experiment description: |
Conversely, deletion of this enhancer via CRISPR/Cas9 reduces C/EBP? expression and its genome-wide co-occupancy with BRD4 at H3K27ac-marked enhancers and super-enhancers |
About SNP
Upstream Pathway Annotation of TF
| GeneName |
Pathway Name |
Source |
Gene Number |
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene
Expression of target genes for the
enhancer
Enhancer associated SNPs